The People

Medicare Patients Become Eligible for GLP-1 Weight-Loss Drugs Starting July 1

via Washington Examiner·Jun 30

Starting July 1, Medicare patients can access GLP-1 weight-loss drugs under a new CMS pilot program, broadening coverage for the popular but costly medications. The change marks a significant expansion of obesity treatment for older Americans.

Read Full Story at Washington Examiner
Health

Related Stories

Hegseth Unveils Mandatory Testosterone Screening for Service Members Over 30

Washington Examiner·22h ago

French Lawmakers Approve Assisted Dying Law With Strict Rules After Years of Debate

BBC World·yesterday

Extreme Heat Warnings as a 'Heat Dome' Bakes Much of the U.S.

The Guardian·yesterday

New Anti-Amyloid Treatment Offers Alzheimer's Patients a Fighting Chance

Fox News·yesterday
DiscussSoon
← Front Page